CN101586256A - 多孔性电纺纤维的制备方法 - Google Patents
多孔性电纺纤维的制备方法 Download PDFInfo
- Publication number
- CN101586256A CN101586256A CNA2009100319478A CN200910031947A CN101586256A CN 101586256 A CN101586256 A CN 101586256A CN A2009100319478 A CNA2009100319478 A CN A2009100319478A CN 200910031947 A CN200910031947 A CN 200910031947A CN 101586256 A CN101586256 A CN 101586256A
- Authority
- CN
- China
- Prior art keywords
- electrospun fiber
- electrospinning
- polymer
- salt
- porosity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 124
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- 238000001523 electrospinning Methods 0.000 claims abstract description 93
- 239000003814 drug Substances 0.000 claims abstract description 49
- 150000003839 salts Chemical class 0.000 claims abstract description 38
- 239000002131 composite material Substances 0.000 claims abstract description 35
- 229920000642 polymer Polymers 0.000 claims abstract description 30
- 239000002245 particle Substances 0.000 claims abstract description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 80
- 239000004632 polycaprolactone Substances 0.000 claims description 44
- 229920001610 polycaprolactone Polymers 0.000 claims description 44
- 239000007788 liquid Substances 0.000 claims description 40
- 239000011780 sodium chloride Substances 0.000 claims description 40
- 229930012538 Paclitaxel Natural products 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 23
- 229960001592 paclitaxel Drugs 0.000 claims description 23
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 23
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 15
- 229960002897 heparin Drugs 0.000 claims description 15
- 229920000669 heparin Polymers 0.000 claims description 15
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 13
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 13
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 229920000954 Polyglycolide Polymers 0.000 claims description 11
- 239000004633 polyglycolic acid Substances 0.000 claims description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 5
- 229960005489 paracetamol Drugs 0.000 claims description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 claims description 4
- 229920005615 natural polymer Polymers 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 229920001059 synthetic polymer Polymers 0.000 claims description 4
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 2
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims description 2
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims description 2
- 102000008946 Fibrinogen Human genes 0.000 claims description 2
- 108010049003 Fibrinogen Proteins 0.000 claims description 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims description 2
- 102100021866 Hepatocyte growth factor Human genes 0.000 claims description 2
- 102000007625 Hirudins Human genes 0.000 claims description 2
- 108010007267 Hirudins Proteins 0.000 claims description 2
- 108010025020 Nerve Growth Factor Proteins 0.000 claims description 2
- 102000015336 Nerve Growth Factor Human genes 0.000 claims description 2
- 102000048238 Neuregulin-1 Human genes 0.000 claims description 2
- 108090000556 Neuregulin-1 Proteins 0.000 claims description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 2
- 101710098940 Pro-epidermal growth factor Proteins 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 claims description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 claims description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 2
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 claims description 2
- 229930101531 artemisinin Natural products 0.000 claims description 2
- 229920001400 block copolymer Polymers 0.000 claims description 2
- 229940112869 bone morphogenetic protein Drugs 0.000 claims description 2
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 claims description 2
- 229910000020 calcium bicarbonate Inorganic materials 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- -1 carrene Chemical compound 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 2
- 229960003957 dexamethasone Drugs 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 229960001123 epoprostenol Drugs 0.000 claims description 2
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 claims description 2
- 229940012952 fibrinogen Drugs 0.000 claims description 2
- 229940006607 hirudin Drugs 0.000 claims description 2
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims description 2
- 229940053128 nerve growth factor Drugs 0.000 claims description 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 2
- 229930183339 qinghaosu Natural products 0.000 claims description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 2
- 229960002930 sirolimus Drugs 0.000 claims description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 11
- 239000011148 porous material Substances 0.000 abstract description 5
- 238000003912 environmental pollution Methods 0.000 abstract description 3
- 230000017423 tissue regeneration Effects 0.000 abstract description 3
- 230000003746 surface roughness Effects 0.000 abstract description 2
- 238000010828 elution Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 36
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 239000002657 fibrous material Substances 0.000 description 9
- 229910001220 stainless steel Inorganic materials 0.000 description 8
- 239000010935 stainless steel Substances 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000000399 optical microscopy Methods 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241001466460 Alveolata Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/24—Formation of filaments, threads, or the like with a hollow structure; Spinnerette packs therefor
- D01D5/247—Discontinuous hollow structure or microporous structure
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Mechanical Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nonwoven Fabrics (AREA)
- Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100319478A CN101586256B (zh) | 2009-07-06 | 2009-07-06 | 多孔性电纺纤维的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100319478A CN101586256B (zh) | 2009-07-06 | 2009-07-06 | 多孔性电纺纤维的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101586256A true CN101586256A (zh) | 2009-11-25 |
CN101586256B CN101586256B (zh) | 2011-05-25 |
Family
ID=41370678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100319478A Expired - Fee Related CN101586256B (zh) | 2009-07-06 | 2009-07-06 | 多孔性电纺纤维的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101586256B (zh) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101891292A (zh) * | 2010-07-27 | 2010-11-24 | 北京师范大学 | 一种快速吸附去除水中微量多环芳烃的方法 |
CN101953801A (zh) * | 2010-10-20 | 2011-01-26 | 重庆大学 | 可程序性控制给药的核/壳结构纳微粒多药给药***的制备方法 |
CN102071485A (zh) * | 2010-12-06 | 2011-05-25 | 北京化工大学常州先进材料研究院 | 一种制备含孔结构纳米纤维的方法 |
EP2457652A1 (en) | 2010-11-24 | 2012-05-30 | Technicka Univerzita v Liberci | Chromatographic substrate for thin-layer chromatography and chromatographic substrate for column chromatography |
EP2530189A1 (en) | 2011-06-01 | 2012-12-05 | Technicka Univerzita V Liberci | Method of production of functional nanofiber layer and device for carrying out the method |
CN102886068A (zh) * | 2012-09-21 | 2013-01-23 | 暨南大学 | 一种plga纳米纤维支架的制备及其在组织工程中的应用 |
CN103046145A (zh) * | 2011-10-17 | 2013-04-17 | 三门峡兴邦特种膜科技发展有限公司 | 连续制备纳米纤维膜的装置 |
CN103276475A (zh) * | 2013-05-30 | 2013-09-04 | 常熟理工学院 | 一种杂多酸与金属氧化物复合纳米纤维的制备方法 |
CN103469353A (zh) * | 2013-09-07 | 2013-12-25 | 河北联合大学 | 磷钼酸/聚丙烯酸/聚乙烯醇复合纤维的制备工艺 |
CN103656758A (zh) * | 2012-09-26 | 2014-03-26 | 中国科学院化学研究所 | 一种仿天然血管中膜层结构与功能的组织工程支架及其制备方法 |
CN105133067A (zh) * | 2015-09-07 | 2015-12-09 | 佛山轻子精密测控技术有限公司 | 一种可控孔径的多孔纳米纤维的制造方法 |
CN104611784B (zh) * | 2014-12-31 | 2016-08-24 | 四川大学 | 高压静电纺丝制备的负载多烯紫杉醇含纳米孔网络纤维及其应用 |
CN106109054A (zh) * | 2016-08-19 | 2016-11-16 | 上海交通大学医学院附属上海儿童医学中心 | 利用大孔径平行聚己内酯电纺棉构建自体组织工程血管 |
CN107737364A (zh) * | 2017-11-23 | 2018-02-27 | 广州市众为生物技术有限公司 | 一种创伤敷料及其制备方法 |
CN110295401A (zh) * | 2019-07-08 | 2019-10-01 | 安徽农业大学 | 一种纯壳聚糖超细纤维的制备方法 |
CN111719244A (zh) * | 2020-06-18 | 2020-09-29 | 山东理工大学 | 一种具有青蒿素缓释功能的聚己内酯/胶原复合纳米纤维膜的制备 |
CN113756013A (zh) * | 2021-09-14 | 2021-12-07 | 厦门数字智造工业研究院有限公司 | 一种二级孔结构的纳米纤维膜及其制备方法 |
-
2009
- 2009-07-06 CN CN2009100319478A patent/CN101586256B/zh not_active Expired - Fee Related
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101891292A (zh) * | 2010-07-27 | 2010-11-24 | 北京师范大学 | 一种快速吸附去除水中微量多环芳烃的方法 |
CN101953801A (zh) * | 2010-10-20 | 2011-01-26 | 重庆大学 | 可程序性控制给药的核/壳结构纳微粒多药给药***的制备方法 |
EP2457652A1 (en) | 2010-11-24 | 2012-05-30 | Technicka Univerzita v Liberci | Chromatographic substrate for thin-layer chromatography and chromatographic substrate for column chromatography |
CN102071485A (zh) * | 2010-12-06 | 2011-05-25 | 北京化工大学常州先进材料研究院 | 一种制备含孔结构纳米纤维的方法 |
EP2530189A1 (en) | 2011-06-01 | 2012-12-05 | Technicka Univerzita V Liberci | Method of production of functional nanofiber layer and device for carrying out the method |
CN103046145A (zh) * | 2011-10-17 | 2013-04-17 | 三门峡兴邦特种膜科技发展有限公司 | 连续制备纳米纤维膜的装置 |
CN103046145B (zh) * | 2011-10-17 | 2016-01-27 | 三门峡兴邦特种膜科技发展有限公司 | 连续制备纳米纤维膜的装置 |
CN102886068A (zh) * | 2012-09-21 | 2013-01-23 | 暨南大学 | 一种plga纳米纤维支架的制备及其在组织工程中的应用 |
CN103656758B (zh) * | 2012-09-26 | 2014-12-10 | 中国科学院化学研究所 | 一种仿天然血管中膜层结构与功能的组织工程支架及其制备方法 |
CN103656758A (zh) * | 2012-09-26 | 2014-03-26 | 中国科学院化学研究所 | 一种仿天然血管中膜层结构与功能的组织工程支架及其制备方法 |
CN103276475B (zh) * | 2013-05-30 | 2015-04-15 | 常熟理工学院 | 一种杂多酸与金属氧化物复合纳米纤维的制备方法 |
CN103276475A (zh) * | 2013-05-30 | 2013-09-04 | 常熟理工学院 | 一种杂多酸与金属氧化物复合纳米纤维的制备方法 |
CN103469353A (zh) * | 2013-09-07 | 2013-12-25 | 河北联合大学 | 磷钼酸/聚丙烯酸/聚乙烯醇复合纤维的制备工艺 |
CN104611784B (zh) * | 2014-12-31 | 2016-08-24 | 四川大学 | 高压静电纺丝制备的负载多烯紫杉醇含纳米孔网络纤维及其应用 |
CN105133067A (zh) * | 2015-09-07 | 2015-12-09 | 佛山轻子精密测控技术有限公司 | 一种可控孔径的多孔纳米纤维的制造方法 |
CN105133067B (zh) * | 2015-09-07 | 2017-07-28 | 佛山轻子精密测控技术有限公司 | 一种可控孔径的多孔纳米纤维的制造方法 |
CN106109054A (zh) * | 2016-08-19 | 2016-11-16 | 上海交通大学医学院附属上海儿童医学中心 | 利用大孔径平行聚己内酯电纺棉构建自体组织工程血管 |
CN107737364A (zh) * | 2017-11-23 | 2018-02-27 | 广州市众为生物技术有限公司 | 一种创伤敷料及其制备方法 |
CN110295401A (zh) * | 2019-07-08 | 2019-10-01 | 安徽农业大学 | 一种纯壳聚糖超细纤维的制备方法 |
CN111719244A (zh) * | 2020-06-18 | 2020-09-29 | 山东理工大学 | 一种具有青蒿素缓释功能的聚己内酯/胶原复合纳米纤维膜的制备 |
CN113756013A (zh) * | 2021-09-14 | 2021-12-07 | 厦门数字智造工业研究院有限公司 | 一种二级孔结构的纳米纤维膜及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101586256B (zh) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101586256B (zh) | 多孔性电纺纤维的制备方法 | |
Huang et al. | Fabrication of porous fibers via electrospinning: strategies and applications | |
CN100387762C (zh) | 一种聚丙烯腈基介孔-大孔超细碳纤维及其制备方法 | |
Huang et al. | Fabricating porous poly (lactic acid) fibres via electrospinning | |
Soltani et al. | Recent progress in the design and synthesis of nanofibers with diverse synthetic methodologies: characterization and potential applications | |
CN102068339B (zh) | 一种载有药物的可生物降解的纳米纤维医用敷料制备方法 | |
Ma et al. | Electrospinning of polycaprolacton/chitosan core-shell nanofibers by a stable emulsion system | |
DE10040897B4 (de) | Nanoskalige poröse Fasern aus polymeren Materialien | |
CN101187111B (zh) | 用于医用敷料含纳米银明胶/壳聚糖复合纳米纤维毡及制备 | |
CN104383606B (zh) | 一种高强度高弹性血管支架及其制备方法 | |
Zdraveva et al. | Electrospun nanofibers | |
Wei et al. | The multifunctional wound dressing with core–shell structured fibers prepared by coaxial electrospinning | |
CN102266582A (zh) | 载有药物纳米纤维医用敷料制备方法 | |
CN103590132A (zh) | 一种多孔结构静电纺丝纳米纤维的制备方法 | |
CN103820943B (zh) | 大孔三维有序取向性丝素蛋白纳米纤维支架及其制备方法 | |
CN106400305A (zh) | 一种大孔静电纺纳米纤维膜的制备方法 | |
Soyekwo et al. | Highly permeable cellulose acetate nanofibrous composite membranes by freeze-extraction | |
Taskin et al. | Emerging wet electrohydrodynamic approaches for versatile bioactive 3D interfaces | |
CN103143060B (zh) | 具有有序等级纳米结构的三维多孔膜的制备方法 | |
CN109722722B (zh) | 一种均孔纳米纤维及其制备方法和应用 | |
JP2008261064A (ja) | 海綿状繊維立体構造体とその製造方法 | |
KR101112774B1 (ko) | 용융 전기방사에 의해 구현된 활성탄소섬유 및 그 제조방법 | |
Corradini et al. | Preparation of polymeric mats through electrospinning for technological uses | |
CN106498508A (zh) | 一种聚乳酸静电纺丝溶液的制备方法 | |
CN108864472B (zh) | 一种超薄微孔丝素蛋白膜、制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU HAICHUAN BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: JIANGSU TAILING BIOLOGICAL TECHNOLOGY CO., LTD. Effective date: 20121012 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 225300 TAIZHOU, JIANGSU PROVINCE TO: 225300 ZHENJIANG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121012 Address after: Leng Yu Lu Dantu high tech Development Zone in Jiangsu Province, Zhenjiang City, No. 168, 225300 Patentee after: Jiangsu HIDream Biotechnology Co., Ltd. Address before: 118, room 2, building 1, 225300 drug City Avenue, Jiangsu, Taizhou Patentee before: Jiangsu Tailing Biological Technology Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: JIANGSU CHANGJIYONG BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: JIANGSU HIDREAM BIOTECHNOLOGY CO., LTD. Effective date: 20130111 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130111 Address after: Hi tech park south latitude four road 225300 in Jiangsu province Zhenjiang City No. 36 Patentee after: Jiangsu Changjiyong Biotechnology Co., Ltd. Address before: Leng Yu Lu Dantu high tech Development Zone in Jiangsu Province, Zhenjiang City, No. 168, 225300 Patentee before: Jiangsu HIDream Biotechnology Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110525 Termination date: 20180706 |
|
CF01 | Termination of patent right due to non-payment of annual fee |